Seegene

Seegene built its reputation on multiplex real-time PCR technology and demonstrated its capabilities during the COVID-19 pandemic by distributing its own SARS-CoV-2 test worldwide from April onwards.

Today, the company supports laboratories with a broad molecular diagnostics portfolio covering respiratory and gastrointestinal infections, sexually transmitted infections, HPV, tuberculosis, healthcare-associated infections and more. Thanks to its patented technology and strong focus on automation, Seegene enables laboratories in more than 80 countries to deliver faster, more accurate diagnoses.

Seegene

Would you like to find out more about this manufacturer's products?

Other manufacturers

UniRay
Varian
DEKA
Hamilton Company